Identification of cancer chemopreventive isothiocyanates as direct inhibitors of the arylamine N-acetyltransferase-dependent acetylation and bioactivation of aromatic amine carcinogens
Autor: | Romain Duval, Ximing Xu, Jean-Marie Dupret, Linh-Chi Bui, Robert H. Dodd, Fernando Rodrigues-Lima, Kevin Cariou, Cécile Mathieu, Emile Petit |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Arylamine N-Acetyltransferase Breast Neoplasms Toxicology 03 medical and health sciences DNA Adducts Isothiocyanates Tumor Cells Cultured Humans carcinogen metabolism cancer chemoprevention Amines Enzyme Inhibitors enzyme inhibition Carcinogen chemistry.chemical_classification Arylamine N-acetyltransferase Chemistry Carcinogen Metabolism Aromatic amine arylamine carcinogens Acetylation isothiocyanate phytochemicals 3. Good health Kinetics 030104 developmental biology Enzyme Oncology Biochemistry Docking (molecular) Carcinogens Female Cysteine Research Paper |
Zdroj: | Oncotarget |
ISSN: | 1949-2553 |
Popis: | Aromatic amines (AAs) are chemicals of industrial, pharmacological and environmental relevance. Certain AAs, such as 4-aminobiphenyl (4-ABP), are human carcinogens that require enzymatic metabolic activation to reactive chemicals to form genotoxic DNA adducts. Arylamine N-acetyltransferases (NAT) are xenobiotic metabolizing enzymes (XME) that play a major role in this carcinogenic bioactivation process. Isothiocyanates (ITCs), including benzyl-ITC (BITC) and phenethyl-ITC (PEITC), are phytochemicals known to have chemopreventive activity against several aromatic carcinogens. In particular, ITCs have been shown to modify the bioactivation and subsequent mutagenicity of carcinogenic AA chemicals such as 4-ABP. However, the molecular and biochemical mechanisms by which these phytochemicals may modulate AA carcinogens bioactivation and AA-DNA damage remains poorly understood. This manuscript provides evidence indicating that ITCs can decrease the metabolic activation of carcinogenic AAs via the irreversible inhibition of NAT enzymes and subsequent alteration of the acetylation of AAs. We demonstrate that BITC and PEITC react with NAT1 and inhibit readily its acetyltransferase activity (k(i) = 200 M(-1).s(-1) and 66 M(-1).s(-1) for BITC and PEITC, respectively). Chemical labeling, docking approaches and substrate protection assays indicated that inhibition of the acetylation of AAs by NAT1 was due to the chemical modification of the enzyme active site cysteine. Moreover, analyses of AAs acetylation and DNA adducts in cells showed that BITC was able to modulate the endogenous acetylation and bioactivation of 4-ABP. In conclusion, we show that direct inhibition of NAT enzymes may be an important mechanism by which ITCs exert their chemopreventive activity towards AA chemicals. |
Databáze: | OpenAIRE |
Externí odkaz: |